To accelerate the use of genomic data in patient care, the National Human Genome Research Institute (NHGRI) will invest $40 million over 4 years in multidisciplinary research projects at 5 institutions. Two of the institutions—Baylor College of Medicine in Houston and the University of Washington in Seattle—will focus on how to introduce sequencing into cancer genetics clinics, while the others will examine its role in various noncancerous conditions.

“At NHGRI, we foresee genome sequencing becoming a routine part of medical care,” says Bradley Ozenberger, PhD, program director for Genomic Medicine. “These projects are exploring the best ways to widen the use of genomic medicine in an effective, responsible, respectful way.”

In one of the cancer studies, 280 children diagnosed with brain and other solid tumors at Texas Children's Cancer Center will have exome sequencing of tumor and blood samples performed while they receive standard treatment for their cancer, says Baylor's...

You do not currently have access to this content.